Rare diseases are often multifaceted, and a single endpoint is often not sufficient to fully describe treatment

Radiopharmaceutical therapy utilizes radioactive atoms to target and precisely treat cancer cells.

Lionel RIOU FRANÇA, Chief Scientific Officer, was involved in two analyses involving patients with Late-Onset Pompe…

Cell and gene therapies are multiplying, and with them the hopes of patients, their families, and healthcare professionals…

Flexibility and Speed In Early Phase Clinical Trials Written by Crista Casey, Executive VP Global Head of Operations First and…

How to cut the negative impact of protocol amendments Social distancing laws in response to the COVID-19 pandemic forced dramatic…

We were ready for COVID-19 Written by Crista Casey, Executive VP Global Head, Operations in my home office surrounded by…

Recipe for Success in Radiopharmaceutical Studies Written by Sue Batchelor, Senior Director, Clinical Operations and Delivery Radiopharmaceutical studies are not…

Cervical cancer and the call to eradicate it Right now, a global movement to eliminate cervical cancer is being driven…

Biotechnology’s Trusted Partner from Start to Finish Aixial Group’s team of clinical experts can support your biotechnology company in the…

Partnering to Advance Research and End Pediatric Cancers Throughout the year, and especially during Childhood Cancer Awareness Month every September,…

Recent Advancements in Glioblastoma Studies How Aixial Group applies 30+ years’ oncology trial experience to help find new therapies An…